FindTrial
Sign In

The clinical significance of Chinese herbal medicine pretreatment in patients with repeated implantation failure induced to uterine cavity disease

The clinical significance of Chinese herbal medicine pretreatment in patients with repeated implantation failure induced to uterine cavity disease1

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16007945
Enrollment
Unknown
Registered
2016-02-18
Start date
2016-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Treatment Group:Traditional Chinese Medicine
Control Group:hysteroscope

Sponsors

Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. the freieze cycle of repeated implantaton failure patients; 2. obtained quality embryos; 3. intrauterine disease; 4. Aged<40 years.

Exclusion criteria

Exclusion criteria: Exclude patents with repeated implantation failure due to other diseases and acute genital tract infection including its combined systematic diseases. Exclude patients who are currently involved in other clinical trial as well as patients determined to be unfit for clinical trials by the researchers.

Design outcomes

Primary

MeasureTime frame
Clincal pregnancy rate;—

Secondary

MeasureTime frame
Biochemical pregnancy rate;abortion rate;Endometrial thickness on implantation day;—

Countries

China

Contacts

Public ContactYanping Kuang
kuangyanp@126.com+86 021-232716999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026